Hamak Gold Limited Npv Di — £1.66 million Amended Funding Package

Hamak’s funding restructure buys time, but real business progress remains unproven and opaque.

What the company is saying

Hamak Strategy Limited is telling investors that it has successfully renegotiated its debt, converting a previous £2.5 million convertible loan note into a new non-convertible loan of £1,657,671.23 with YA II PN Ltd. The company emphasizes that this restructuring comes with no penalties and only £20,000 in legal fees, framing the deal as cost-effective and shareholder-friendly. Management highlights the unchanged 4% interest rate and a ten-month repayment schedule starting 60 days after the new agreement, suggesting a manageable and predictable debt burden. The announcement spotlights the issuance of 165,767,123 warrants at £0.01 per share—a 54% premium to the July 2026 offer price—implying confidence in future share price appreciation and alignment with the lender’s interests. Hamak claims the new structure provides a 'cleaner platform' for executing its strategy at a critical stage, using language that suggests a turning point or inflection in the company’s development. The company also notes it can retain the first £110,000 from its At The Market Facility, with half of further proceeds going to loan repayment, which is positioned as preserving operational flexibility. The narrative is upbeat, projecting confidence and control, but it is heavy on forward-looking statements and light on operational or financial specifics. The Board acknowledges risks related to holding Bitcoin in treasury, but provides no detail on exposure or risk mitigation. Notable individuals named include Mike Murphy (Chief Strategy Officer), Karl Smithson (CEO), and Annabelle Wills (role unknown), but the announcement does not attribute any particular significance to their involvement beyond standard executive roles. Overall, the messaging is designed to reassure investors that Hamak is managing its capital structure proactively and is poised for future growth, even though the operational path to that growth is not described.

What the data suggests

The disclosed numbers confirm that Hamak has replaced a £2.5 million convertible loan note with a £1,657,671.23 non-convertible loan, reducing its headline debt obligation. The interest rate remains at 4% per annum, and the only restructuring cost is £20,000 in legal fees, which is modest relative to the loan size. The repayment schedule is set to begin 60 days after the agreement and will run for ten months, but there is no cash flow or liquidity data to assess whether these terms are sustainable for the company. The company will issue 165,767,123 warrants at £0.01 per share, which, if fully exercised, could generate approximately £1.66 million in gross proceeds—though this is entirely contingent on future share price performance and investor appetite. There is no breakdown or calculation provided to verify that the number of warrants and exercise price exactly match the projected proceeds, nor is there any information on the likelihood or timing of warrant exercise. The company’s ability to retain the first £110,000 from its At The Market Facility and apply 50% of further proceeds to loan repayment is a minor liquidity buffer, but the scale of ATM activity is not disclosed. Critically, there are no financial statements, revenue figures, or operational metrics provided, so it is impossible to determine whether Hamak is generating cash, burning cash, or even operating at all. The only operational detail is the mention of Bitcoin holdings, but no amounts or valuation are disclosed. An independent analyst would conclude that while the funding terms are clearly laid out, the absence of broader financial data makes it impossible to assess the company’s financial health, trajectory, or ability to deliver on its strategic ambitions.

Analysis

The announcement is positive in tone, focusing on the successful amendment of a significant funding arrangement and the issuance of warrants. The core realised facts are the execution of the amended loan agreement and the specific terms disclosed (loan amount, interest rate, legal fees, warrant issuance). However, the narrative inflates the significance by projecting potential future benefits (e.g., 'cleaner platform from which to execute its strategy', 'potentially generating approximately £1.66 million of gross cash proceeds if exercised in full') that are not yet realised and depend on future events (warrant exercise, operational execution). No profitability, revenue, or operational metrics are disclosed, so the actual financial impact and sustainability of the business remain unknown. The capital outlay is material, and the benefits (warrant proceeds, strategic execution) are contingent and not immediate. The gap between narrative and evidence is moderate: the funding terms are clear, but the broader business impact is unsubstantiated.

Risk flags

• ●Operational opacity: The announcement provides no information on current operations, production, or revenue, making it impossible to assess whether the company is a going concern or simply a financial shell. This lack of transparency is a major risk for investors seeking to understand the underlying business.
• ●Financial disclosure gap: There are no income statements, cash flow statements, or balance sheet data provided. Without these, investors cannot evaluate liquidity, solvency, or profitability, which are critical for assessing the company’s ability to service debt and fund operations.
• ●Forward-looking dependency: A significant portion of the claimed benefits—such as the £1.66 million in potential warrant proceeds—are entirely contingent on future events (warrant exercise, share price appreciation) that may never materialize. This introduces substantial uncertainty and execution risk.
• ●Capital intensity with delayed payoff: The company is taking on a material debt obligation and issuing a large number of warrants, but the payoff from these actions (if any) is not immediate and depends on future market conditions and operational success.
• ●Bitcoin treasury risk: The company holds some reserves in Bitcoin, but provides no detail on the amount or risk management strategy. Bitcoin’s volatility and regulatory uncertainty could expose Hamak to unexpected losses or liquidity constraints.
• ●Repayment risk: The loan amortization schedule requires repayments over ten months, but with no disclosed cash flow or revenue, it is unclear whether Hamak can meet these obligations without further dilution or asset sales.
• ●Disclosure selectivity: The announcement is highly selective, focusing on funding mechanics while omitting any discussion of operational milestones, exploration results, or business development. This pattern suggests management may be prioritizing financial engineering over substantive business progress.
• ●Management alignment: While the issuance of warrants is framed as aligning the lender with future equity performance, there is no evidence that management or insiders are participating on the same terms, nor is there any indication of insider buying or direct financial commitment from executives.

Bottom line

For investors, this announcement is a pure capital structure update: Hamak has renegotiated its debt, reducing the principal and shifting from a convertible to a non-convertible facility, while issuing a large block of warrants to the lender. The company’s narrative is confident and positions the deal as a strategic enabler, but the absence of any operational, revenue, or profitability data means there is no evidence that Hamak is generating value or even operating as a viable business. The only realized facts are the new loan terms and the issuance of warrants; all other benefits are speculative and depend on future events that may not occur. The involvement of named executives is standard and does not signal additional institutional confidence or insider commitment. To change this assessment, Hamak would need to disclose detailed financial statements, operational milestones, and evidence of cash generation or business progress. Investors should watch for the next reporting period to see if any operational updates, revenue figures, or cash flow data are provided, as well as whether the company meets its loan repayment schedule without further dilution. At present, this announcement is worth monitoring but not acting on: it signals that Hamak has bought itself time, but provides no basis for confidence in future value creation. The single most important takeaway is that Hamak’s funding restructure is a stopgap, not a solution—without operational progress or financial transparency, the investment case remains unproven.

Announcement summary

(LSE: HAMA / OTCQB: HASTF) Hamak Strategy Limited has entered into an amendment and restatement of its existing funding arrangements with YA II PN Ltd, resulting in a non-convertible loan of £1,657,671.23. The previous £2.5 million convertible loan note announced on 4 December 2025 has been restated into this new non-convertible facility, with no penalties and only £20,000 of legal fees incurred. The interest rate remains at 4% per annum, and amortisation will commence 60 days after entry into the new loan agreement, followed by a ten-month repayment schedule. Hamak may retain the first £110,000 of cash raised through its existing At The Market Facility, with 50% of further ATM proceeds applied to reduce the outstanding loan balance. The company will issue 165,767,123 warrants to the lender, exercisable at £0.01 per share (a 54% premium to the offer price on 1 July 2026), potentially generating approximately £1.66 million of gross cash proceeds if exercised in full. The company maintains some of its treasury reserves and surplus cash in Bitcoin, and the Board of Directors has identified risks related to Bitcoin volatility and market regulation. The company projects that the new funding structure gives Hamak a cleaner platform from which to execute its strategy at an important stage in the Company's development.

Disagree with this article?